Makoto Ueno
Beth Israel Deaconess Medical Center(US)Harvard University(US)Keio University(JP)Yokohama City University Medical Center(JP)Kanagawa Prefectural Hospital Organization(JP)Kanagawa Children's Medical Center(JP)Kanagawa Cancer CenterYokohama City University(JP)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics, Gallbladder and Bile Duct Disorders, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial(2023)937 cited
- → The varicella zoster virus vasculopathies(2008)531 cited
- → Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies(2020)488 cited
- → Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies(2020)356 cited
- → Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study(2019)329 cited
- → Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial